MAIA Biotechnology公司近日公布了其药物Thio-101在非小细胞肺癌2期临床试验中取得的积极疗效数据,为该公司的癌症治疗研发项目带来重要进展。
MAIA Biotechnology公司近日公布了其药物Thio-101在非小细胞肺癌2期临床试验中取得的积极疗效数据,为该公司的癌症治疗研发项目带来重要进展。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.